We are excited to introduce the TP Pivot Pro™ for transperineal prostate biopsy procedures to UK healthcare professionals. Developed by the dedicated team at CIVCO Medical Solutions, this device enables a smarter approach to prostate biopsies.
The TP Pivot Pro is a disposable needle-guide designed to enhance the benefits of the minimally invasive, freehand transperineal biopsy approach. Research suggests that the transperineal approach, as opposed to the transrectal, can lead to reduced risks of infections and may even eliminate the need for antibiotics following these procedures.
The device is designed with a pivoting coaxial needle that can adjust up to 20 degrees upwards and downwards from its initial parallel path, ensuring precise and full access to the prostate. Additionally, it is compatible with the vast majority of ultrasound probes - without the requirement for tape. Furthermore, the needle height can be adjusted without being removed from the guide or the patient, which helps reduce the number of needle insertions.
CIVCO's TP Pivot Pro™ Needle Guide
CIVCO is committed to enhancing the safety of image guided procedures, and the TP Pivot Pro is a big step forward on this journey. At Mermaid Medical, we always strive to form valuable partnerships that help improve patient lives, and our collaboration with CIVCO is a prime example.
“I am very pleased with, and proud of, our partnership with CIVCO - and the TP Pivot Pro marks a major milestone on our joint journey towards improving patient outcomes,” said Lars Vinther, CEO of Mermaid Medical Group. “Our relationship with CIVCO and its management spans over 17 years, which is a testament to our long-standing collaboration and dedication. This enduring partnership has allowed Mermaid Medical to become a key partner in supporting CIVCO’s launch of novel technologies. Over the years, we have consistently demonstrated our commitment and capability to drive innovation and enhance patient care.”
Discover how the TP Pivot Pro™ offers a smarter approach to prostate biopsies:
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Mermaid Medical proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.